Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03661177 · ClinicalTrials.gov registry record · NA

Reclaiming Indigenous Food and Health

A NA study, sponsored by University of Wyoming.

Completed
Registry status
NA
Development phase
19
Enrollment target

NCT03661177: Completed NA study, sponsored by University of Wyoming.

NCT03661177 is a NA study that has completed, run by University of Wyoming. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03661177, a NA study, has completed, sponsored by University of Wyoming.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target

Study Summary

The overall purpose of this proposed action-research project is to measure the feasibility of consuming and the impact of indigenous plants and foods on health outcomes among Native American participants.

Primary Outcome

Body mass index (using height and weight) will be measured using a portable stadiometer (to measure height) + Tanita Analyzer (to measure weight). Body mass index parameters for health (i.e. healthy weight is equivalent to a BMI between 18.5-24.9) will be evaluated.

Interventions

  • OTHER Sovereign nation diet

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2020-01-16
Est. Completion 2024-06-05
Phase NA
University of Wyoming

15 total trials

What the finished NCT03661177 record still lists

NCT03661177 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Sovereign nation diet is the first listed.

NCT03661177 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03661177 about?

NCT03661177 is a clinical study titled "Reclaiming Indigenous Food and Health". The overall purpose of this proposed action-research project is to measure the feasibility of consuming and the impact of indigenous plants and foods on health outcomes among Native American participants.

What is the current status of trial NCT03661177?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2020-01-16. Estimated completion is 2024-06-05.

What interventions are being tested in trial NCT03661177?

The interventions under investigation include: Sovereign nation diet (OTHER).

Who is sponsoring clinical trial NCT03661177?

This trial is sponsored by University of Wyoming, which has 15 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03661177's enrollment target sits among peer trials

19 1861st of 2000 higher than 138 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03661177, the US trial registry maintained by the National Library of Medicine. NCT03661177 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.